Penicillin-binding protein-mediated resistance in pneumococci and staphylococci

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 2, 1999, Pages

  Chambers, Henry F ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; IMIPENEM; MEROPENEM; METICILLIN; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TICARCILLIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIAL GENE; BINDING AFFINITY; CONFERENCE PAPER; DNA TRANSPOSITION; GENE EXPRESSION; GENETIC CONSERVATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROTEIN TARGETING; STAPHYLOCOCCUS; STAPHYLOCOCCUS SCIURI; STREPTOCOCCUS PNEUMONIAE;

EID: 0033402097     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513854     Document Type: Conference Paper

References (58)

1. 1. Ghuysen JM. Molecular structures of penicillin-binding proteins and beta-lactamases. Trends Microbiol 1994; 2:372-80.
2. 2. Georgopapadakou NH, Dix BA, Mauriz YR. Possible physiological functions of penicillin-binding proteins in Staphylococcus aureus. Antimicrob Agents Chemother 1986; 29:333-6.
3. 3. Reynolds PE. The essential nature of staphylococcal penicillin-binding proteins. In: Actor P, Daneo-Moore L, Higgins ML, Salton MR, Shockman GD, eds. Antibiotic inhibition of bacterial cell surface assembly and function. Washington, DC: American Society for Microbiology, 1988:343-51.
4. 4. Henze UU, Berger-Bächi B. Staphylococcus aureus penicillin-binding protein 4 and intrinsic beta-lactam resistance. Antimicrob Agents Chemother 1995; 39:2415-22.
5. 5. John CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994; 18:188-93.
6. 6. Laible G, Hackenbeck R. Five independent combinations of mutations can result in low-affinity penicillin binding protein 2x of Streptococcus pneumoniae. J Bacteriol 1991; 173:6986-90.
7. 7. Selakovitch-Chenu L, Giammarinario P, Sicard M. Molecular characterization of a mutation affecting the amount of Streptococcus pneumoniae penicillin binding protein 3. Microb Drug Resist 1997; 3:259-62.
8. 8. Dowson CG, Hutchison A, Spratt BG. Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol Microbiol 1989; 3:95-102.
9. 9. Dowson CG, Hutchison A, Brannigan JA, et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989; 86: 8842-6.
10. 10. Laible G, Spratt B, Hackenbeck R. Inter-species recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991; 5: 1993-2002.
11. 11. Schrag SJ, Perrot V, Levin BR. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc Lond B Biol Sci 1997; 264: 1287-91.
12. 12. Severin A, Vaz Pato MV, Sá Figueiredo AM, Tomasz A. Drastic changes in the peptidoglycan composition of penicillin resistant laboratory mutants of Streptococcus pneumoniae. FEMS Microbiol Lett 1995; 130: 31-5.
13. 13. Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961; 14: 385-93.
14. 14. Benner EJ, Kayser FH. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet 1968; 2:741-4.
15. 15. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus infection and colonization. J Chemother 1995; 7(suppl 3): 99-103.
16. 16. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-8.
17. 17. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10: 781-91.
18. 18. Hiramatsu K, Konodo N, Ito T. Genetic basis for molecular epidemiology of MRSA. J Infect Chemother 1996; 2:117-29.
19. 19. Kuhl SA, Pattee PA, Baldwin JN. Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus. J Bacteriol 1978; 135:460-5.
20. 20. Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 1984; 158:513-6.
21. 21. Archer GL, Niemeyer DM, Thanassi JA, Pucci MJ. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob Agents Chemother 1994; 38:447-54.
22. 22. Chambers HF. Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produced penicillin-binding protein 2a. Antimicrob Agents Chemother 1987; 31:919-24.
23. 23. Reynolds PE, Fuller C. Methicillin-resistant strains of Staphylococcus aureus: presence of identical additional penicillin-binding protein in all strains examined. FEMS Microbiol Lett 1986; 33:251-4.
24. 24. Ubukata K, Nonoguchi R, Song MD, Matsuhashi M, Konno M. Homology of mecA gene in methicillin-resistant Staphylococcus haemolyticus and Staphylococcus simulans to that of Staphylococcus aureus. Antimicrob Agents Chemother 1990; 34:170-12.
25. 25. Matsuhashi M, Song MD, Ishimo F, et al. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol 1986; 167: 975-80.
26. 26. Song MD, Wachi M, Doi M, Ishino F, Matsuhashi M. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett 1987; 221:167-71.
27. 27. Wu S, Piscitelli C, deLencastre H, Tomasz A. Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microb Drug Resist 1996; 2:435-41.
28. 28. Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol 1995; 39:531-4.
29. 29. Kreiswirth B, Komblum J, Arbeit RD, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1993; 259: 227-30.
30. 30. Archer GL, Niemeyer DM. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol 1994; 2: 343-7.
31. 31. Gillespie MT, Lyon BR, Loo LS, Matthews PR, Stewart PR, Skurray RA. Homologous direct repeat sequences associated with mercury, methicillin, tetracycline, and trimethoprim resistance determinants in Staphylococcus aureus. FEMS Microbiol Lett 1987; 43:165-71.
32. 32. Tesch W, Ryffel C, Strässle A, Kayser FH, Berger-Bächi B. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2′. Antimicrob Agents Chemother 1990; 34:1703-6.
33. 33. Hiramatsu K, Asada K, Suzuki E, Okonogi K, Yokota T. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett 1992; 298:133-6.
34. 34. Dyke K, Gregory P. Resistance to beta-lactam antibiotics: resistance mediated by beta-lactamases. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997: 139-57.
35. 35. Hürlimann-Dalel RL, Ryffel C, Kayser FH, Berger-Bächi B. Survey of the methicillin resistance-associated genes mecA, mecRI-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1992; 36:2617-21.
36. 36. Hackbarth CJ, Chambers HF. blaI and blaRI regulate beta-lactamase and PBP 2a production in methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother 1993; 37:1144-9.
37. 37. Ubukata K, Nonoguchi R, Matsuhashi M, Konno M. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol 1989; 171:2882-5.
38. 38. Kuwahara-Arai K, Kondo N, Hori S, Tateda-Suzuki E, Hiramatsu K. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus is caused by the mecl-mediated repression of PBP2′ production. Antimicrob Agents Chemother 1996; 40: 2680-5.
39. 39. Ryffel C, Kayser FH, Berger-Bächi B. Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob Agents Chemother 1992; 36:25-31.
40. 40. Niemeyer DM, Pucci MJ, Thanassi SA, Sharma VK, Archer GL. Role of mecA transcriptional regulation in the phenotypic expression of methicillin résistance in Staphylococcus aureus. J Bacteriol 1996; 178: 5464-71.
41. 41. Matthews PR, Reed KC, Stewart PR. The cloning of chromosomal DNA associated with methicillin and other resistances in Staphylococcus aureus. J Gen Microbiol 1987; 133:1919-29.
42. 42. Skinner S, Inglis B, Matthews PR, Stewart PR. Mercury and tetracycline resistance genes and flanking repeats associated with methicillin resistance on the chromosome of Staphylococcus aureus. Mol Microbiol 1988; 2:289-97.
43. 43. Dubin DT, Matthews PR, Chikramane SG, Stewart PR. Physical mapping of the mec region of an American methicillin-resistant Staphylococcus aureus strain. Antimicrob Agents Chemother 1991; 35:1661-5.
44. 44. Hartman BJ, Tomasz A. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother 1986; 29:85-92.
45. 45. Matthews PR, Stewart PR. Resistance heterogeneity in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 1984; 22:161-6.
46. 46. Sabath LD, Wallace SJ. Factors influencing methicillin resistance in staphylococci. Ann NY Acad Sci 1974; 236:258-66.
47. 47. Cohen SC, Gibson J, Sweeney HM. Phenotypic suppression of methicillin resistance in Staphylococcus aureus by mutant noninducible penicillinase plasmids. J Bacteriol 1972; 112:682-9.
48. 48. Hackbarth CJ, Miick C, Chambers HF. Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1994; 38:2578-81.
49. 49. Berger-Bächi B. Insertional inactivation of staphylococcal methicillin resistance by Tn551. J Bacteriol 1983; 154:479-87.
50. 50. Berger-Bächi B. Resistance to beta-lactam antibiotics: resistance not mediated by beta-lactamases (methicillin resistance). In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997:158-67.
51. 51. Murakami K, Tomasz A. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J Bacteriol 1989; 171:874-9.
52. 52. de Jonge BL, Sidow T, Chang YS, et al. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J Bacteriol 1993; 175:2779-82.
53. 53. Gustafson J, Strässle A, Hächler H, Kayser FH, Berger-Bächi B. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J Bacteriol 1994; 176: 1460-7.
54. 54. de Jonge BL, Chang YS, Gage D, Tomasz A. Peptidoglycan composition in heterogeneous Tn51 mutants of a methicillin-resistant Staphylococcus aureus strain. J Biol Chem 1992; 267:11255-9.
55. 55. Ornelas-Soares A, de Lancastre H, de Jonge BL, Tomasz A. Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan. J Biol Chem 1994; 269:27246-50.
56. 56. Maki H, Yamaguchi T, Murakami K. Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus. J Bacteriol 1994; 176:4993-5000.
57. 57. Píriz-Durán S, Kayser FH, Berger-Bächi B. Impact of sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett 1996; 141:255-60.
58. 58. de Jonge BL, Chang YS, Gage D, Tomasz A. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. J Biol Chem 1992; 267:11248-54.